Akt expression and compartmentalization in prediction of clinical outcome in HER2-positive metastatic breast cancer patients treated with trastuzumab

By                  

International Journal of Oncology, Vol. 41, Iss. 4, 2012-01 ,pp. : 1204-1212

Spandidos Publications

Access to resources Recommend Favorite

Comment on: Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

By Errante Domenico   Bernardi Daniele   Bianco Antonio   Salvagno Luigi  

Acta Oncologica, Vol. 46, Iss. 4, 2007-01 ,pp. : 565-566

Informa Healthcare

Access to resources Recommend Favorite

Incidence, pattern and timing of brain metastases among patients with advanced breast cancer treated with trastuzumab

By Yau Thomas   Swanton Charles   Chua Sue   Sue Ashley   Walsh Geraldine   Rostom A.   Johnston Stephen   O'Brien Mary   Smith Ian  

Acta Oncologica, Vol. 45, Iss. 2, 2006-03 ,pp. : 196-201

Informa Healthcare

Access to resources Recommend Favorite

Membrane-bound complement regulatory proteins are prognostic factors of operable breast cancer treated with adjuvant trastuzumab: A retrospective study

By  

Oncology Reports, Vol. 32, Iss. 6, 2014-01 ,pp. : 2619-2627

Spandidos Publications

Access to resources Recommend Favorite

Trastuzumab and gemcitabine as salvage therapy in heavily pre-treated patients with metastatic breast cancer

By Bartsch Rupert   Wenzel Catharina   Gampenrieder Simon   Pluschnig Ursula   Altorjai Gabriela   Rudas Margaretha   Mader Robert   Dubsky Peter   Rottenfusser Andrea   Gnant Michael   Zielinski Christoph   Steger Guenther  

Cancer Chemotherapy and Pharmacology, Vol. 62, Iss. 5, 2008-10 ,pp. : 903-910

Springer Publishing Company

Access to resources Recommend Favorite